Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032

Female Contraceptives Market Report Overview

The female contraceptives market sales across the 7MM was $7.8 billion in 2022. The market is expected to achieve a CAGR of less than 1% during 2022-2032. During the forecast period, sales of female contraceptives will increase in the UK due to the rising female population. Conversely, sales in France, Germany, Italy, and Spain markets will decrease owing to the declining female population.

Female Contraceptives Market Outlook, 2022-2032 ($ Billion)

Buy the Full Report to Know More about the Female Contraceptives Market Forecast

Download A Free Report Sample

The Female Contraceptives market research report provides a granular forecast growth analysis for both global and regional markets through 2032. The report covers an exhaustive study of the countries wherein the market is prevalent, leading players, current treatment options, and factors driving the market growth. Furthermore, the pipeline valuation analysis and information on the market’s unmet needs and opportunities will help in determining potential business possibilities.

Female Contraceptives Market Drivers

• The launch of one new pipeline drug in the US, Spain, and the UK, and the two marketed drugs in Japan will help accelerate market growth during the forecast period.
• The growing populations of the US and the UK will result in increased sales throughout the forecast period.
• The continued success of oral contraceptives.
• Increased use of other methods of contraceptives, such as intrauterine devices (IUDs), transdermal patches, and vaginal gels will increase growth in some of the 7MM.

Female Contraceptives Market Segmentation by Countries

The US had the highest share of the 7MM in 2022 and will continue to lead during the forecast period

A few of the key countries wherein the female contraceptives market is prevalent are the US, France, Germany, Italy, Spain, the UK, and Japan. The leading female contraceptives market in the US will experience moderate growth during the forecast period, primarily due to the increasing sales of vaginal gel, Phexxi.

Japan had the least sales of the 7MM in 2022. The lack of launches of new contraceptives in the country, a decrease in the female population, Japan’s culture, and the current attitude toward premarital sex among the younger generation confer great opportunities for foreign drug developers to enter the Japanese contraceptive market at the moment.

Female Contraceptives Market Analysis by Countries, 2022 (%)

Buy the Full Report for More Country Insights into the Female Contraceptives Market

Download A Free Report Sample

Female Contraceptives Market Segmentation by Classes

A few of the female contraceptive classes are oral contraceptives, hormonal intrauterine devices, vaginal rings, transdermal patches, and subcutaneous implants, among others. Oral contraceptives accounted for the highest sales in the US, 5EU, and Japanese female contraceptives market in 2022. In Japan, only three of the drug classes are currently approved, namely oral contraceptives, hormonal IUDs, and intramuscular injections.

Female Contraceptives Market Analysis by Classes, 2022 (%)

Buy the Full Report for More Class Insights into the Female Contraceptives Market

Download A Free Report Sample

Female Contraceptives Market - Competitive Landscape

Bayer is a global market leader in the field of hormonal contraception

A few of the major players in the female contraceptives market are:

• Bayer
• Allergan (AbbVie)
• Merck
• Pfizer
• Organon

Female Contraceptives Market Analysis by Players (%)

Buy the Full Report to Know More about Companies in the Female Contraceptives Market

Download A Free Report Sample

Segments Covered in the Report

Female Contraceptives Country Outlook (Value, $ Billion, 2022-2032)

• The US
• France
• Germany
• Italy
• Spain
• The UK
• Japan

Female Contraceptives Class Outlook (Value, $ Billion, 2022-2032)

• Oral Contraceptives
• Hormonal Intrauterine Devices
• Vaginal Rings
• Transdermal Patches
• Subcutaneous Implants
• Intramuscular Injections
• Vaginal Gels

Scope

The report provides:

• Overview of Female Contraceptives.
• Annualized Female Contraceptives therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2022 to 2032.
• Key topics including strategic competitor assessment, market characterization, unmet needs, and clinical trial mapping. The report also includes implications of these factors for the Female Contraceptives therapeutics market.
• Comprehensive data assessing emerging trends and mechanisms of action under development for Female Contraceptives. The most promising candidates in late-stage development are profiled.
• Analysis of the current and future market competition in the global Female Contraceptive therapeutics market. The report also contains an insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

Key Highlights

Female contraceptives market will slightly grow during the forecast period, at a CAGR of 0.5%.

Late-stage pipeline therapies are anticipated to drive slight but not significant growth in the contraceptives market.

Hormonal contraceptives with reduced adverse reactions, non-hormonal contraceptives, better compliance and adherence to contraceptives, access to a wide range of contraceptives and awareness of different contraceptive methods are the greatest unmet needs in the contraceptives space.

Reasons to Buy

• Develop and design in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the 7MM Female Contraceptives therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM Female Contraceptives therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.